e-therapeutics plc announced a restructuring of the Board and Management Team. Iain Ross is standing down as Non-Executive Chairman to concentrate on his interim Executive Chairman role at Silence Therapeutics plc. Ali Mortazavi has been appointed Executive Chairman with immediate effect.

Mr. Mortazavi has extensive experience in the biotechnology sector and financial markets. Recent roles include CEO of Silence Therapeutics plc from 2012-2018 as well as a founder shareholder of Evolution Group. Ray Barlow has stood down as Chief Executive Officer with immediate effect but has agreed to remain with the Company for a period of time to provide support to Ali Mortazavi and ensure an effective transition.

Steve Medlicott, Chief Financial Officer, has also stood down from the Board with immediate effect. Trevor Jones will remain as an Independent Non-Executive Director and Michael Bretherton has been appointed as Non-Executive Director to replace Christine Soden who is also standing down from the Board. The Company intends to appoint a further independent non-executive director to the Board in due course.